Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S)-2-[(2S)-2-[(2S)-2-{[(1R,4S,7R,10S,16S,19S,22S,25S,31S,37S,43S,46R,51R,54S,57S,60S,63S,69R,72S,78S,84S,87R)-78-(4-aminobutyl)-87-(2-aminoacetamido)-60-benzyl-43-[(2S)-butan-2-yl]-4,57-bis(3-carbamimidamidopropyl)-84-(2-carboxyethyl)-19,25-bis[(1R)-1-hydroxyethyl]-54-(hydroxymethyl)-10-(1H-indol-3-ylmethyl)-63-(2-methylpropyl)-2,5,8,11,17,20,23,26,32,35,38,41,44,53,56,59,62,65,68,71,77,80,83,86,93,96,99,102-octacosaoxo-22,37-bis(propan-2-yl)-48,49,89,90,104,105-hexathia-3,6,9,12,18,21,24,27,33,36,39,42,45,52,55,58,61,64,67,70,76,79,82,85,92,95,98,101-octacosaazahexacyclo[49.40.11.4^{7,69}.0^{12,16}.0^{27,31}.0^{72,76}]106n-46-yl]formamido}-3-hydroxypropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid
ID: ALA1078514
PubChem CID: 46883522
Max Phase: Preclinical
Molecular Formula: C134H207N41O42S6
Molecular Weight: 3256.78
Molecule Type: Protein
Associated Items: